Pathobiology of human cerebrovascular malformations: Basic mechanisms and clinical relevance

Neurosurgery

Volumn 55, Issue 1, 2004, Pages 1-16

  Gault, Judith ^a   Sarin, Hemant ^a   Awadallah, Nabil A ^b   Shenkar, Robert ^c   Awad, Issam A ^c,d  

^a UNIVERSITY OF COLORADO   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d EVANSTON NORTHWESTERN HEALTHCARE   (United States)

Author keywords

Angiogenesis; Arteriovenous malformations; Cerebral cavernous malformations; Hereditary hemorrhagic telangiectasia; Vasculogenesis

Indexed keywords

ANGIOPOIETIN; ANGIOPOIETIN RECEPTOR; BASIC FIBROBLAST GROWTH FACTOR; BASIC FIBROBLAST GROWTH FACTOR RECEPTOR; CYTOSKELETON PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ARTERIOVENOUS MALFORMATION; BENIGN VEIN MALFORMATION; BRAIN CAPILLARY; CAPILLARY MALFORMATION; CELL ADHESION; CELL COMMUNICATION; CELL CULTURE; CELL DIFFERENTIATION; CELL JUNCTION; CELL MATURATION; CEREBRAL CAVERNOUS MALFORMATION; CEREBROVASCULAR MALFORMATION; CYTOLOGY; DISEASE CLASSIFICATION; DISEASE COURSE; FAMILIAL DISEASE; FOCAL NEUROLOGICAL DEFICIT; GENE EXPRESSION; GENE INTERACTION; GENE MUTATION; GENE THERAPY; GENETIC COUNSELING; GENETICS; HISTOPATHOLOGY; HUMAN; MOLECULAR BIOLOGY; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NEURORADIOLOGY; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RENDU OSLER WEBER DISEASE; REVIEW; SCREENING; SEIZURE; SIGNAL TRANSDUCTION; STROKE; ULTRASTRUCTURE; VEIN MALFORMATION;

BRAIN; CEREBROVASCULAR DISORDERS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; SIGNAL TRANSDUCTION;

EID: 3042824996     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (171)

1. Abbott NJ, Revest PA, Romero IA: Astrocyte-endothelial interaction: Physiology and pathology. Neuropathol Appl Neurobiol 18:424-433, 1992.
2. Abdulrauf SI, Kaynar MY, Awad IA: A comparison of the clinical profile of cavernous malformations with and without associated venous malformations. Neurosurgery 44:41-47, 1999.
3. Achen MG, Stacker SA: The vascular endothelial growth factor family: Proteins which guide the development of the vasculature. Int J Exp Pathol 79:255-265, 1998.
4. Arthur HM, Ure J, Smith AJ, Renforth G, Wilson DI, Torsney E, Charlton R, Parums DV, Jowett T, Marchuk DA, Bum J, Diamond AG: Endoglin, an ancillary TGFβ receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev Biol 217:42-53, 2000.
5. Ausprunk DH, Folkman J: Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc Res 14:53-65, 1977.
6. Awad IA, Barrow DL (eds): Cavernous Malformations. Park Ridge, AANS, 1993.
7. Awad IA, Robinson JR: Comparison of the clinical presentation of symptomatic arteriovenous malformations (angiographically visualized) and occult vascular malformations. Neurosurgery 32:876-878, 1993.
8. Awad IA, Robinson JR Jr, Mohanty S, Estes ML: Mixed vascular malformations of the brain: Clinical and pathogenetic considerations. Neurosurgery 33:179-188, 1993.
9. Baev NI, Awad IA: Endothelial cell culture from human cerebral cavernous malformations. Stroke 29:2426-2434, 1998.
10. Baev NI, Wong J, Awad IA: Arteriovenous Malformations in Functional Areas of the Brain. Armonk, New York, Futura Publishing Co., 1999.
11. Basilico C, Moscatelli D: The FGF family of growth factors and oncogenes. Adv Cancer Res 59:115-165, 1992.
12. Beck L Jr, D'Amore PA: Vascular development: Cellular and molecular regulation. FASEB J 11:365-373, 1997.
13. Benckert C, Jonas S, Cramer T, Von Marschall Z, Schafer G, Peters M, Wagner K, Radke C, Wiedenmann B, Neuhaus P, Hocker M, Rosewicz S: Transforming growth factor β1 stimulates vascular endothelial growth factor gene transcription in human cholangiocellular carcinoma cells. Cancer Res 63:1083-1092, 2003.
14. Berg JN, Gallione CJ, Stenzel TT, Johnson DW, Allen WP, Schwartz CE, Jackson CE, Porteous ME, Marchuk DA: The activin receptor-like kinase 1 gene: Genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2. Am J Hum Genet 61:60-67, 1997.
15. Berg JN, Guttmacher AE, Marchuk DA, Porteous ME: Clinical heterogeneity in hereditary haemorrhagic telangiectasia: Are pulmonary arteriovenous malformations more common in families linked to endoglin? J Med Genet 33:256-257, 1996.
16. Boudreau NJ, Jones PL: Extracellular matrix and integrin signalling: The shape of things to come. Biochem J 339:481-488, 1999.
17. Bourdeau A, Cymerman U, Paquet ME, Meschino W, McKinnon WC, Guttmacher AE, Becker L, Letarte M: Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1. Am J Pathol 156:911-923, 2000.
18. Bourdeau A, Dumont DJ, Letarte M: A murine model of hereditary hemorrhagic telangiectasia. J Clin Invest 104:1343-1351, 1999.
19. Bourdeau A, Faughnan ME, McDonald ML, Paterson AD, Wanless IR, Letarte M: Potential role of modifier genes influencing transforming growth factor-β1 levels in the development of vascular defects in endoglin heterozygous mice with hereditary hemorrhagic telangiectasia. Am J Pathol 158:2011-2020, 2001.
20. Bruner JM TR, McLendon RE: Tumors of vascular origin, in Bigner DD, McLendon RE, Bruner JM (eds): Russell and Rubinstein's Pathology of Tumors of the Nervous System. London, Arnold, 1998, pp 239-293.
21. Brunereau L, Labauge P, Tournier-Lasserve E, Laberge S, Levy C, Houtteville JP: Familial form of intracranial cavernous angioma: MR imaging findings in 51 families-French Society of Neurosurgery. Radiology 214: 209-216, 2000.
22. Brunereau L, Leveque C, Bertrand P, Tranquart E, Cordoliani Y, Rouleau P, Labauge P: Familial form of cerebral cavernous malformations: Evaluation of gradient-spin-echo (GRASE) imaging in lesion detection and characterization at 1.5 T. Neuroradiology 43:973-979, 2001.
23. Byzova TV, Goldman CK, Pampori N, Thomas KA, Bett A, Shattil SJ, Plow EF: A mechanism for modulation of cellular responses to VEGF: Activation of the integrins. Mol Cell 6:851-860, 2000.
24. Calvert JT, Riney TJ, Kontos CD, Cha EH, Prieto VG, Shea CR, Berg JN, Nevin NC, Simpson SA, Pasyk KA, Speer MC, Peters KG, Marchuk DA: Allelic and locus heterogeneity in inherited venous malformations. Hum Mol Genet 8:1279-1289, 1999.
25. Carlson TR, Feng Y, Maisonpierre PC, Mrksich M, Morla AO: Direct cell adhesion to the angiopoietins mediated by integrins. J Biol Chem 276: 26516-26525, 2001.
26. Carmeliet P, Collen D: Role of vascular endothelial growth factor and vascular endothelial growth factor receptors in vascular development. Curr Top Microbiol Immunol 237:133-158, 1999.
27. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A: Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380:435-439, 1996.
28. Cave-Riant F, Denier C, Labauge P, Cecillon M, Maciazek J, Joutel A, Laberge-Le Couteulx S, Tournier-Lasserve E: Spectrum and expression analysis of KRIT1 mutations in 121 consecutive and unrelated patients with cerebral cavernous malformations. Eur J Hum Genet 10:733-740, 2002.
29. Chabas D, Baranzini SE, Mitchell D, Bernard CC, Rittling SR, Denhardt DT, Sobel RA, Lock C, Karpuj M, Pedotti R, Heller R, Oksenberg JR, Steinman L: The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 294:1731-1735, 2001.
30. Challa VR, Moody DM, Brown WR: Vascular malformations of the central nervous system. J Neuropathol Exp Neurol 54:609-621, 1995.
31. Chen Y, Swanson RA: Astrocytes and brain injury. J Cereb Blood Flow Metab 23:137-149, 2003.
32. Chen DH, Lipe HP, Qin Z, Bird TD: Cerebral cavernous malformation: Novel mutation in a Chinese family and evidence for heterogeneity. J Neurol Sci 196:91-96, 2002.
33. Clatterbuck RE, Eberhart CG, Crain BJ, Rigamonti D: Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations. J Neurol Neurosurg Psychiatry 71:188-192, 2001.
34. Craig HD, Gunel M, Cepeda O, Johnson EW, Ptacek L, Steinberg GK, Ogilvy CS, Berg MJ, Crawford SC, Scott RM, Steichen-Gersdorf E, Sabroe R, Kennedy CT, Mettler G, Beis MJ, Fryer A, Awad IA, Lifton RP: Multilocus linkage identifies two new loci for a mendelian form of stroke, cerebral cavernous malformation, at 7p15-13 and 3q25.2-27. Hum Mol Genet 7:1851-1858, 1998.
35. Cymerman U, Vera S, Pece-Barbara N, Bourdeau A, White RI Jr, Dunn J, Letarte M: Identification of hereditary hemorrhagic telangiectasia type 1 in newborns by protein expression and mutation analysis of endoglin. Pediatr Res 47:24-35, 2000.
36. Davenport WJ, Siegel AM, Dichgans J, Drigo P, Mammi I, Pereda P, Wood NW, Rouleau GA: CCM1 gene mutations in families segregating cerebral cavernous malformations. Neurology 56:540-543, 2001.
37. Del Curling O Jr, Kelly DL Jr, Elster AD, Craven TE: An analysis of the natural history of cavernous angiomas. J Neurosurg 75:702-708, 1991.
38. Diaz-Flores L, Gutierrez R, Varela H: Angiogenesis: An update. Histol Histopathol 9:807-843, 1994.
39. Dickson MC, Martin JS, Cousins FM, Kulkarni AB, Karlsson S, Akhurst RJ: Defective haematopoiesis and vasculogenesis in transforming growth factor-β1 knock out mice. Development 121:1845-1854, 1995.
40. DiMario J, Buffinger N, Yamada S, Strohman RC: Fibroblast growth factor in the extracellular matrix of dystrophic (mdx) mouse muscle. Science 244:688-690, 1989.
41. Dubovsky J, Zabramski JM, Kurth J, Spetzler RF, Rich SS, Orr HT, Weber JL: A gene responsible for cavernous malformations of the brain maps to chromosome 7q. Hum Mol Genet 4:453-458, 1995.
42. Dvorak HF: VPF/VEGF and the angiogenic response. Semin Perinatol 24:75-78, 2000.
43. Eerola I, McIntyre B, Vikkula M: Identification of eight novel 5′-exons in cerebral capillary malformation gene-1 (CCM1) encoding KRIT1. Biochim Biophys Acta 1517:464-467, 2001.
44. Eliceiri BP, Klemke R, Stromblad S, Cheresh DA: Integrin αvβ3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis. J Cell Biol 140:1255-1263, 1998.
45. Ferrara N: Vascular endothelial growth factor and the regulation of angiogenesis. Recent Prog Horm Res 55:15-36, 2000.
46. Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ, Moore MW: Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380:439-442, 1996.
47. Flamme I, Breier G, Risau W: Vascular endothelial growth factor (VEGF) and VEGF receptor 2 (flk-1) are expressed during vasculogenesis and vascular differentiation in the quail embryo. Dev Biol 169:699-712, 1995.
48. Folkman J, D'Amore PA: Blood vessel formation: What is its molecular basis? Cell 87:1153-1155, 1996.
49. Folkman J, Klagsbrun M, Sasse J, Wadzinski M, Ingber D, Vlodavsky I: A heparin-binding angiogenic protein-basic fibroblast growth factor-is stored within basement membrane. Am J Pathol 130:393-400, 1988.
50. Fong GH, Rossant J, Gertsenstein M, Breitman ML: Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376:66-70, 1995.
51. Fulbright RK, Chaloupka JC, Putman CM, Sze GK, Merriam MM, Lee GK, Fayad PB, Awad IA, White RI Jr: MR of hereditary hemorrhagic telangiectasia: Prevalence and spectrum of cerebrovascular malformations. AJNR Am J Neuroradiol 19:477-484, 1998.
52. Gale NW, Yancopoulos GD: Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev 13:1055-1066, 1999.
53. Gallagher AR, Hidaka S, Gretz N, Witzgall R: Molecular basis of autosomal-dominant polycystic kidney disease. Cell Mol Life Sci 59:682-693, 2002.
54. Gallione CJ, Klaus DJ, Yeh EY, Stenzel TT, Xue Y, Anthony KB, McAllister KA, Baldwin MA, Berg JN, Lux A, Smith JD, Vary CP, Craigen WJ, Westermann CJ, Warner ML, Miller YE, Jackson CE, Guttmacher AE, Marchuk DA: Mutation and expression analysis of the endoglin gene in hereditary hemorrhagic telangiectasia reveals null alleles. Hum Mutat 11:286-294, 1998.
55. Gerhardt H, Betsholtz C: Endothelial-pericyte interactions in angiogenesis. Cell Tissue Res 314:15-23, 2003.
56. Grant DS, Kleinman HK, Goldberg ID, Bhargava MM, Nickoloff BJ, Kinsella JL, Polverini P, Rosen EM: Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci U S A 90:1937-1941, 1993.
57. Gunel M, Awad IA, Finberg K, Anson JA, Steinberg GK, Batjer HH, Kopitnik TA, Morrison L, Giannotta SL, Nelson-Williams C, Lifton RP: A founder mutation as a cause of cerebral cavernous malformation in Hispanic Americans. N Engl J Med 334:946-951, 1996.
58. Gunel M, Laurans MS, Shin D, DiLuna ML, Voorhees J, Choate K, Nelson-Williams C, Lifton RP: KRIT1, a gene mutated in cerebral cavernous malformation, encodes a microtubule-associated protein. Proc Natl Acad Sci U S A 99:10677-10682, 2002.
59. Guttmacher AE, Marchuk DA, White RI Jr: Hereditary hemorrhagic telangiectasia. N Engl J Med 333:918-924, 1995.
60. Haigh JJ, Gerber HP, Ferrara N, Wagner EF: Conditional inactivation of VEGF-A in areas of collagen2a1 expression results in embryonic lethality in the heterozygous state. Development 127:1445-1453, 2000.
61. Haitjema T, Disch F, Overtoom TT, Westermann CJ, Lammers JW: Screening family members of patients with hereditary hemorrhagic telangiectasia. Am J Med 99:519-524, 1995.
62. Hashimoto T, Wen G, Lawton MT, Boudreau NJ, Bollen AW, Yang GY, Barbaro NM, Higashida RT, Dowd CF, Halbach VV, Young WL: Abnormal expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in brain arteriovenous malformations. Stroke 34:925-931, 2003.
63. Herzig R, Burval S, Vladyka V, Janouskova L, Krivanek P, Krupka B, Vlachova I, Urbanek K: Familial occurrence of cerebral arteriovenous malformation in sisters: Case report and review of the literature. Eur J Neurol 7:95-100, 2000.
64. Hocevar BA, Brown TL, Howe PH: TGF-β induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J 18:1345-1356, 1999.
65. Ingber D: Extracellular matrix and cell shape: Potential control points for inhibition of angiogenesis. J Cell Biochem 47:236-241, 1991.
66. Jafar JJ, Awad IA, Rosenwasser RH (eds): Vascular Malformations of the Central Nervous System. Philadelphia, Lippincott Williams & Wilkins, 1999.
67. Johnson DW, Berg JN, Gallione CJ, McAllister KA, Warner JP, Helmbold EA, Markel DS, Jackson CE, Porteous ME, Marchuk DA: A second locus for hereditary hemorrhagic telangiectasia maps to chromosome 12. Genome Res 5:21-28, 1995.
68. Jones N, Iljin K, Dumont DJ, Alitalo K: Tie receptors: New modulators of angiogenic and lymphangiogenic responses. Nat Rev Mol Cell Biol 2:257-267, 2001.
69. Kamiryo T, Nelson PK, Bose A, Zalzal P, Jafar JJ: Familial arteriovenous malformations in siblings. Surg Neurol 53:255-259, 2000.
70. Kawasaki T, Kitsukawa T, Bekku Y, Matsuda Y, Sanbo M, Yagi T, Fujisawa H: A requirement for neuropilin-1 in embryonic vessel formation. Development 126:4895-4902, 1999.
71. Kehrer-Sawatzki H, Wilda M, Braun VM, Richter HP, Hameister H: Mutation and expression analysis of the KRIT1 gene associated with cerebral cavernous malformations (CCM1). Acta Neuropathol (Berl) 104: 231-240, 2002.
72. Kilic T, Pamir MN, Kullu S, Eren F, Ozek MM, Black PMcL: Expression of structural proteins and angiogenic factors in cerebrovascular anomalies. Neurosurgery 46:1179-1192, 2000.
73. Kjeldsen AD, Vase P, Green A: Hereditary haemorrhagic telangiectasia: A population-based study of prevalence and mortality in Danish patients. J Intern Med 245:31-39, 1999.
74. Klein S, Bikfalvi A, Birkenmeier TM, Giancotti FG, Rifkin DB: Integrin regulation by endogenous expression of 18-kDa fibroblast growth factor-2. J Biol Chem 271:22583-22590, 1996.
75. Knudson AG: Two genetic hits (more or less) to cancer. Nat Rev Cancer 1:157-162, 2001.
76. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG, Strieter RM: Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258:1798-1801, 1992.
77. Kontos CD, Annex BH: Angiogenesis. Curr Atheroscler Rep 1:165-171, 1999.
78. Kubota K, Okazaki J, Louie O, Kent KC, Liu B: TGF-β stimulates collagen (I) in vascular smooth muscle cells via a short element in the proximal collagen promoter. J Surg Res 109:43-50, 2003.
79. Labauge P, Brunereau L, Levy C, Laberge S, Houtteville JP: The natural history of familial cerebral cavernomas: A retrospective MRI study of 40 patients. Neuroradiology 42:327-332, 2000.
80. Laberge-le Couteulx S, Jung HH, Labauge P, Houtteville JP, Lescoat C, Cecillon M, Marechal E, Joutel A, Bach JF, Tournier-Lasserve E: Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas. Nat Genet 23:189-193, 1999.
81. Laurans MS, DiLuna ML, Shin D, Niazi F, Voorhees JR, Nelson-Williams C, Johnson EW, Siegel AM, Steinberg GK, Berg MJ, Scott RM, Tedeschi G, Enevoldson TP, Anson J, Rouleau GA, Ogilvy C, Awad JA, Lifton RP, Gunel M: Mutational analysis of 206 families with cavernous malformations. J Neurosurg 99:38-43, 2003.
82. Li DY, Sorensen LK, Brooke BS, Urness LD, Davis EC, Taylor DG, Boak BB, Wendel DP: Defective angiogenesis in mice lacking endoglin. Science 284:1534-1537, 1999.
83. Ling L, Goeddel DV: T6BP, a TRAF6-interacting protein involved in IL-1 signaling. Proc Natl Acad Sci U S A 97:9567-9572, 2000.
84. a. Liquori CL, Berg MJ, Siegel AM, Huang E, Zawistowski JS, Stoffer T, Verlaan D, Balogun F, Hughes L, Leedom TP, Plummer NW, Cannella M, Maglione V, Squitieri F, Johnson EW, Roulean GA, Ptacek L, Marchuk DA: Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. Am J Hum Genet 73:1459-1464, 2003.
85. Loughna S, Sato TN: A combinatorial role of angiopoietin-1 and orphan receptor TIE1 pathways in establishing vascular polarity during angiogenesis. Mol Cell 7:233-239, 2001.
86. Lucas M, Costa AF, Montori M, Solano F, Zayas MD, Izquierdo G: Germline mutations in the CCM1 gene, encoding Krit1, cause cerebral cavernous malformations. Ann Neurol 49:529-532, 2001.
87. Lux A, Gallione CJ, Marchuk DA: Expression analysis of endoglin missense and truncation mutations: Insights into protein structure and disease mechanisms. Hum Mol Genet 9:745-755, 2000.
88. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD: Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55-60, 1997.
89. Marchuk DA, Srinivasan S, Squire TL, Zawistowski JS: Vascular morphogenesis: Tales of two syndromes. Hum Mol Genet 12:R97-R112, 2003.
90. Margolis GO, Woodhal B, Bloor BM: The role of small angiomatous malformations in the production of intracerebral hematomas. J Neurosurg 8:564-575, 1951.
91. Massague J: TGF-β signal transduction. Annu Rev Biochem 67:753-791, 1998.
92. McAllister KA, Lennon F, Bowles-Biesecker B, McKinnon WC, Helmbold EA, Markel DS, Jackson CE, Guttmacher AE, Pericak-Vance MA, Marchuk DA: Genetic heterogeneity in hereditary haemorrhagic telangiectasia: Possible correlation with clinical phenotype. J Med Genet 31:927-932, 1994.
93. McCormick WF: The pathology of vascular ("arteriovenous") malformations. J Neurosurg 24:807-816, 1966.
94. Merwin JR, Newman W, Beall LD, Tucker A, Madri J: Vascular cells respond differentially to transforming growth factors β1 and β2 in vitro. Am J Pathol 138:37-51, 1991.
95. Mizuno K, Nakamura T: Molecular characteristics of HGF and the gene, and its biochemical aspects. EXS 65:1-29, 1993.
96. Moses MA: The regulation of neovascularization of matrix metalloproteinases and their inhibitors. Stem Cells 15:180-189, 1997.
97. Moses HL, Serra R: Regulation of differentiation by TGF-β. Curr Opin Genet Dev 6:581-586, 1996.
98. Ng YS, Rohan R, Sunday ME, Demello DE, D'Amore PA: Differential expression of VEGF isoforms in mouse during development and in the adult. Dev Dyn 220:112-121, 2001.
99. Nicosia RF, Nicosia SV, Smith M: Vascular endothelial growth factor, platelet-derived growth factor, and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro. Am J Pathol 145:1023-1029, 1994.
100. Nor JE, Christensen J, Liu J, Peters M, Mooney DJ, Strieter RM, Polverini PJ: Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth. Cancer Res 61:2183-2188, 2001.
101. Nugent MA, Iozzo RV: Fibroblast growth factor-2. Int J Biochem Cell Biol 32:115-120, 2000.
102. Oh SP, Seki T, Goss KA, Imamura T, Yi Y, Donahoe PK, Li L, Miyazono K, ten Dijke P, Kim S, Li E: Activin receptor-like kinase 1 modulates transforming growth factor-β1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci U S A 97:2626-2631, 2000.
103. Ondra SL, Troupp H, George ED, Schwab K: The natural history of symptomatic arteriovenous malformations of the brain: A 24-year follow-up assessment. J Neurosurg 73:387-391, 1990.
104. Ondrick K, Samojla BG: Angiogenesis. Clin Podiatr Med Surg 9:185-202, 1992.
105. Otten P, Pizzolato GP, Rilliet B, Berney J: 131 cases of cavernous angioma (cavernomas) of the CNS, discovered by retrospective analysis of 24,535 autopsies [in French]. Neurochirurgie 35:82-83; 128-131, 1989.
106. Paquet ME, Pece-Barbara N, Vera S, Cymerman U, Karabegovic A, Shovlin C, Letarte M: Analysis of several endoglin mutants reveals no endogenous mature or secreted protein capable of interfering with normal endoglin function. Hum Mol Genet 10:1347-1357, 2001.
107. Pardanaud L, Yassine F, Dieterlen-Lievre F: Relationship between vasculogenesis, angiogenesis and haemopoiesis during avian ontogeny. Development 105:473-485, 1989.
108. Patan S: Vasculogenesis and angiogenesis as mechanisms of vascular network formation, growth and remodeling. J Neurooncol 50:1-15, 2000.
109. Pece N, Vera S, Cymerman U, White RI Jr, Wrana JL, Letarte M: Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative. J Clin Invest 100:2568-2579, 1997.
110. Pece-Barbara N, Cymerman U, Vera S, Marchuk DA, Letarte M: Expression analysis of four endoglin missense mutations suggests that haploinsufficiency is the predominant mechanism for hereditary hemorrhagic telangiectasia type 1. Hum Mol Genet 8:2171-2181, 1999.
111. Pepper MS: Transforming growth factor-β: Vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev 8:21-43, 1997.
112. Peters A, Palay SL, Webster HdeF (eds): The Fine Structure of the Nervous System: Neurons and Their Supporting Cells. New York, Oxford University Press, 1991, ed 3, pp 344-355.
113. Platts SH, Mogford JE, Davis MJ, Meininger GA: Role of K+ channels in arteriolar vasodilation mediated by integrin interaction with RGD-containing peptide. Am J Physiol 275[Suppl 4]:H1449-H1454, 1998.
114. Polymeropoulos MH, Hurko O, Hsu F, Rubenstein J, Basnet S, Lane K, Dietz H, Spetzler RF, Rigamonti D: Linkage of the locus for cerebral cavernous hemangiomas to human chromosome 7q in four families of Mexican-American descent. Neurology 48:752-757, 1997.
115. Pomeroy SL, Tamayo P, Gaasenbeek M, Starla LM, Angelo M, McLaughlin ME, Kim JY, Goumnerova LC, Black PMcL, Lau C, Allen JC, Zagzag D, Olson JM, Curran T, Wetmore C, Biegel JA, Poggio T, Mukherjee S, Rifkin R, Califano A, Stolovitzky G, Louis DN, Mesirov JP, Lander ES, Golub TR: Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415:436-442, 2002.
116. Poole TJ, Finkelstein EB, Cox CM: The role of FGF and VEGF in angioblast induction and migration during vascular development. Dev Dyn 220:1-17, 2001.
117. Putman CM, Chaloupka JC, Fulbright RK, Awad IA, White RI Jr, Fayad PB: Exceptional multiplicity of cerebral arteriovenous malformations associated with hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome). AJNR Am J Neuroradiol 17:1733-1742, 1996.
118. Rhoten RL, Comair YG, Shedid D, Chyatte D, Simonson MS: Specific repression of the preproendothelin-1 gene in intracranial arteriovenous malformations. J Neurosurg 86:101-108, 1997.
119. Risau W: Mechanisms of angiogenesis. Nature 386: 671-674, 1997.
120. Risau W, Flamme I: Vasculogenesis. Annu Rev Cell Dev Biol 11:73-91, 1995.
121. Robinson JR, Awad IA, Little JR: Natural history of the cavernous angioma. J Neurosurg 75:709-714, 1991.
122. Robinson JR Jr, Awad IA, Magdinec M, Paranandi L: Factors predisposing to clinical disability in patients with cavernous malformations of the brain. Neurosurgery 32:730-736, 1993.
123. Robinson JR Jr, Awad IA, Masaryk TJ, Estes ML: Pathological heterogeneity of angiographically occult vascular malformations of the brain. Neurosurgery 33:547-555, 1993.
124. Robinson JR Jr, Awad IA, Zhou P, Bama BP, Estes ML: Expression of basement membrane and endothelial cell adhesion molecules in vascular malformations of the brain: Preliminary observations and working hypothesis. Neurol Res 17:49-58, 1995.
125. Roman G, Fisher M, Perl DP, Poser CM: Neurological manifestations of hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease): Report of 2 cases and review of the literature. Ann Neurol 4:130-144, 1978.
126. Rosen EM, Grant DS, Kleinman HK, Goldberg ID, Bhargava MM, Nickoloff BJ, Kinsella JL, Polverini P: Scatter factor (hepatocyte growth factor) is a potent angiogenesis factor in vivo. Symp Soc Exp Biol 47:227-234, 1993.
127. Rothbart D, Awad IA, Lee J, Kim J, Harbaugh R, Criscuolo GR: Expression of angiogenic factors and structural proteins in central nervous system vascular malformations. Neurosurgery 38:915-925, 1996.
128. Russell DS: The pathology of spontaneous intracranial hemorrhage. Proc R Soc Med 47: 689-693, 1954.
129. Russell DS, Rubinstein LJ: Pathology of Tumors of the Nervous System. Baltimore, Williams & Wilkins, 1989, ed 5.
130. Sahoo T, Johnson EW, Thomas JW, Kuehl PM, Jones TL, Dokken CG, Touchman JW, Gallione CJ, Lee-Lin SQ, Kosofsky B, Kurth JH, Louis DN, Mettler G, Morrison L, Gil-Nagel A, Rich SS, Zabramski JM, Boguski MS, Green ED, Marchuk DA: Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1). Hum Mol Genet 8:2325-2333, 1999.
131. Satchell SC, Harper SJ, Tooke JE, Kerjaschki D, Saleem MA, Mathieson PW: Human podocytes express angiopoietin 1, a potential regulator of glomerular vascular endothelial growth factor. J Am Soc Nephrol 13:544-550, 2002.
132. Sato Y, Shimada T, Takaki R: Autocrinological role of basic fibroblast growth factor on tube formation of vascular endothelial cells in vitro. Biochem Biophys Res Commun 180:1098-1102, 1991.
133. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y: Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376:70-74, 1995.
134. Satomi J, Mount RJ, Toporsian M, Paterson AD, Wallace MC, Harrison RV, Letarte M: Cerebral vascular abnormalities in a murine model of hereditary hemorrhagic telangiectasia. Stroke 34:783-789, 2003.
135. Serebriiskii I, Estojak J, Sonoda G, Testa JR, Golemis EA: Association of Krev-1/rap1a with Krit1, a novel ankyrin repeat-containing protein encoded by a gene mapping to 7q21-22. Oncogene 15:1043-1049, 1997.
136. Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC: Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62-66, 1995.
137. Shenkar R, Elliott JP, Diener K, Gault J, Hu L, Cohrs R, Tzulip P, Hunter L, Breeze R, Awad IA: Differential gene expression in human cerebral vascular malformations. Neurosurgery 52:465-478, 2003.
138. Shovlin CL, Hughes JM, Scott J, Seidman CE, Seidman JG: Characterization of endoglin and identification of novel mutations in hereditary hemorrhagic telangiectasia. Am J Hum Genet 61:68-79, 1997.
139. Singh D, Febbo PG, Ross K, Jackson DG, Manola J, Ladd C, Tamayo P, Renshaw AA, D'Amico AV, Richie JP, Lander ES, Loda M, Kantoff PW, Golub TR, Sellers WR: Gene expression correlates of clinical prostate cancer behavior. Cancer Cell 1:203-209, 2002.
140. Skirgaudas M, Awad IA, Kim J, Rothbart D, Criscuolo G: Expression of angiogenesis factors and selected vascular wall matrix proteins in intracranial saccular aneurysms. Neurosurgery 39:537-547, 1996.
141. Smith DR, Polverini PJ, Kunkel SL, Orringer MB, Whyte RI, Burdick MD, Wilke CA, Strieter RM: Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma. J Exp Med 179:1409-1415, 1994.
142. Sonnenberg E, Meyer D, Weidner KM, Birchmeier C: Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J Cell Biol 123:223-235, 1993.
143. Srinivasan S, Hanes MA, Dickens T, Porteous ME, Oh SP, Hale LP, Marchuk DA: A mouse model for hereditary hemorrhagic telangiectasia (HHT) type 2. Hum Mol Genet 12:473-482, 2003.
144. Sternlicht MD, Werb Z: How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17:463-516, 2001.
145. Strieter RM, Kunkel SL, Arenberg DA, Burdick MD, Polverini PJ: Interferon γ-inducible protein 10 (IP-10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis. Biochem Biophys Res Commun 210:51-57, 1995.
146. Stupack DG, Cheresh DA: ECM remodeling regulates angiogenesis: Endothelial integrins look for new ligands. Sci STKE 119:PE7, 2002.
147. Swerlick RA: Angiogenesis. J Dermatol 22: 845-852, 1995.
148. Tan PH, Manunta M, Ardjomand N, Xue SA, Larkin DF, Haskard DO, Taylor KM, George AJ: Antibody targeted gene transfer to endothelium. J Gene Med 5:311-323, 2003.
149. Tanaka S, Mori M, Sakamoto Y, Makuuchi M, Sugimachi K, Wands JR: Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma. J Clin Invest 103:341-345, 1999.
150. Thorin E, Shatos MA, Shreeve SM, Walters CL, Bevan JA: Human vascular endothelium heterogeneity: A comparative study of cerebral and peripheral cultured vascular endothelial cells. Stroke 28:375-381, 1997.
151. Thurston G, Suri C, Smith K, McClain J, Sato TN, Yancopoulos GD, McDonald DM: Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286:2511-2514, 1999.
152. Trepel M, Grifman M, Weitzman MD, Pasqualini R: Molecular adaptors for vascular-targeted adenoviral gene delivery. Hum Gene Ther 11:1971-1981, 2000.
153. Uranishi R, Baev NI, Kim JH, Awad IA: Vascular smooth muscle cell differentiation in human cerebral vascular malformations. Neurosurgery 49:671-680, 2001.
154. Uranishi R, Baev NI, Ng PY, Kim JH, Awad IA: Expression of endothelial cell angiogenesis receptors in human cerebrovascular malformations. Neurosurgery 48:359-368, 2001.
155. Urness LD, Sorensen LK, Li DY: Arteriovenous malformations in mice lacking activin receptor-like kinase-1. Nat Genet 26:328-331, 2000.
156. Van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH: Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530-536, 2002.
157. Verlaan DJ, Davenport WJ, Stefan H, Sure U, Siegel AM, Rouleau GA: Cerebral cavernous malformations: Mutations in Krit1. Neurology 58: 853-857, 2002.
158. Vikkula M, Boon LM, Carraway KL III, Calvert JT, Diamonti AJ, Goumnerov B, Pasyk KA, Marchuk DA, Warman ML, Cantley LC, Mulliken JB, Olsen BR: Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 87:1181-1190, 1996.
159. Vikkula M, Boon LM, Mulliken JB: Molecular genetics of vascular malformations. Matrix Biol 20:327-335, 2001.
160. Visser JA, Themmen AP: Downstream factors in transforming growth factor-β family signaling. Mol Cell Endocrinol 146:7-17, 1998.
161. Vives KP, Awad IA: Vascular malformations and epilepsy, in Kotargal P, Lüders H (eds): Epilepsy: Etiologies and Treatment. New York, Raven Press Publishers, 1998, pp 371-383.
162. Vuorela P, Hatva E, Lymboussaki A, Kaipainen A, Joukov V, Persico MG, Alitalo K, Halmesmaki E: Expression of vascular endothelial growth factor and placenta growth factor in human placenta. Biol Reprod 56:489-494, 1997.
163. Wallace GM, Shovlin CL: A hereditary haemorrhagic telangiectasia family with pulmonary involvement is unlinked to the known HHT genes, endoglin and ALK-1. Thorax 55:685-690, 2000.
164. Wang HU, Chen ZF, Anderson DJ: Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93:741-753, 1998.
165. Wauder MP, Boval B, Chappey O, Enjolras O, Wernert N, Merland JJ, Wautier JL: Cultured endothelial cells from human arteriovenous malformations have defective growth regulation. Blood 94:2020-2028, 1999.
166. Wong JH, Awad IA, Kim JH: Ultrastructural pathological features of cerebrovascular malformations: A preliminary report. Neurosurgery 46: 1454-1459, 2000.
167. Wright TJ, Leach L, Shaw PE, Jones P: Dynamics of vascular endothelial-cadherin and β-catenin localization by vascular endothelial growth factor-induced angiogenesis in human umbilical vein cells. Exp Cell Res 280: 159-168, 2002.
168. Yamada S: Arteriovenous Malformations in Functional Areas of the Brain. Armonk, Futura Publishing Co., 1999.
169. Yang S, Xin X, Zlot C, Ingle G, Fuh G, Li B, Moffat B, de Vos AM, Gerritsen ME: Vascular endothelial cell growth factor-driven endothelial tube formation is mediated by vascular endothelial cell growth factor receptor-2, a kinase insert domain-containing receptor. Arterioscler Thromb Vasc Biol 21:1934-1940, 2001.
170. Zawistowski JS, Serebriiskli IG, Lee MF, Golernis EA, Marchuk DA: KRIT1 association with the integrin-binding protein 1CAP-1: A new direction in the elucidation of cerebral cavernous malformations (CCM1) pathogenesis. Hum Mol Genet 11:389-396, 2002.
171. Zhang J, Clatterbuck RE, Rigamonti D, Chang DD, Dietz HC: Interaction between krit1 and icap1α infers perturbation of integrin β1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation. Hum Mol Genet 10:2953-2960, 2001.